Buscar
Mostrando ítems 1-1 de 1
Cognitive improvement of acetylcholinesterase inhibitors in schizophrenia
(Journal of Psychopharmacology, 2018-11)
Background: Schizophrenia is a severe, persistent mental disorder, and a leading cause of disability worldwide. Cognitive impairments presented in schizophrenia lead to a worse prognostic, thus treatments targeted to enhance ...